Pricing Log in Create free account

eXoZymes Inc. (EXOZ) vs Grace Therapeutics, Inc. (GRCE)

eXoZymes Inc. and Grace Therapeutics, Inc. are both Biotechnology companies. eXoZymes Inc. and Grace Therapeutics, Inc. are of similar size ($38.1M and $37.5M). Across the 10 metrics below, Grace Therapeutics, Inc. leads on 6 and eXoZymes Inc. on 4.

Valuation

Metric EXOZ GRCE Biotechnology median
P/E n/m n/m 10.60
P/S n/m 160.85 9.40
P/B 10.43 0.67 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 106.08 9.02
Earnings yield (27.05%) (63.44%) (32.88%)
Free cash flow yield (18.74%) (31.78%) (23.13%)

Profitability

Metric EXOZ GRCE Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (187.16%) (36.19%) (51.96%)
Return on assets (115.42%) (33.74%) (46.06%)
Return on invested capital 0.00% (43.36%) 0.00%

Growth

Metric EXOZ GRCE Biotechnology median
Revenue growth (TTM) — 1,286.81% 6.76%
EPS growth (last fiscal year) (22.47%) 40.51% 29.88%
Revenue growth, 5-year CAGR — (22.91%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EXOZ GRCE Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 3.81 11.47 4.97
Net debt to EBITDA 0.31 1.53 1.01

Dividend

Metric EXOZ GRCE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EXOZ GRCE Biotechnology median
Market cap 38.14m 37.45m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack